Company intelligence / Profile preview

ExCEEd Orphan

Prague, Czech Republicexceedorphan.com ↗

Ownership: Private
Development stage: Commercial

Overview

ExCEEd Orphan specializes in providing comprehensive market entry and commercialization services for orphan and ultra-orphan drugs—including gene therapies—across Central & Eastern Europe (CEE). With over a century of cumulative experience among its team members, the company has successfully launched numerous innovative medications in CEE countries. It acts as an expert local partner to small and mid-size biotech/pharma firms lacking direct presence in these markets. A notable example includes supporting AveXis with early access to Zolgensma before EMA approval[1][3][5].

Therapeutic areas: OtherRare Diseases
Modalities: Small molecules (supported for clients)Gene therapies (supported for clients)Biologics/innovative medications (supported for clients)
Industry: Consulting

Drug pipeline

3 assets

maralixibat

Commercial

Indications: Rare diseases

2 more assets in the full pipeline.

Request access →

Partnerships

AveXis/Novartis Gene Therapies (notable past project)*Note*: Partnerships are typically project-based with various biotech/pharma companies seeking market access support.

Beyond the preview

Go deeper on ExCEEd Orphan.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ExCEEd Orphan.

Explore the full profile